
The zzso of zzso therapy for the treatment of anemia is receiving renewed attention due to the current availability of two zzso zzso zzso has been the standard of therapy for patients with zzso disease and zzso anemia for more than a zzso zzso zzso an alternative agent, is now approved for anemia resulting from zzso disease and cancer zzso 

Although direct comparative trials have not been performed with these agents, information published in the last several years regarding their clinical zzso safety, and dosing is zzso in most cases, to compare zzso With the disclaimer that any efficacy comparison of competing products using published reports has certain limitations, a zzso approach from a provider's perspective was zzso 

To provide background for the economic zzso zzso and zzso data for these two agents are zzso Recent clinical trials in the zzso and zzso therapeutic areas are zzso highlighting study designs, dosing regimens, patient entry criteria, study zzso and published zzso Cost data, based on average wholesale prices zzso in 2003, are compared and calculated from available clinical data with an emphasis on zzso 

These evaluations largely conclude that zzso zzso is the better zzso value of the two currently available zzso zzso 

